GPTHEALTH vs MEDANTA: Stock Comparison

GPT HEALTHCARE vs GLOBAL HEALTHUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

GLOBAL HEALTH is the larger company by market capitalisation. GPT HEALTHCARE shows a lower P/E, a higher ROE and a higher dividend yield, while GLOBAL HEALTH shows a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GPTHEALTH leads 7; MEDANTA leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GPTHEALTHMEDANTA

Valuation lens

What price are you paying?

Market CapContext only
₹1,298 Cr
₹38,774 Cr
P/E RatioGPTHEALTH has the lower reading
27.9x
69.7x
P/B RatioGPTHEALTH has the lower reading
4.89x
9.78x
EPSMEDANTA has the higher reading
₹1.55
₹5.9
Book ValueContext only
₹32.84
₹148.18
Dividend YieldGPTHEALTH has the higher reading
1.58%
0.03%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
MEDANTA is the larger company
₹38,774 Cr vs ₹1,298 Cr
P/E Ratio
GPTHEALTH has a lower P/E
27.9x vs 69.7x
P/B Ratio
GPTHEALTH has a lower P/B
4.89x vs 9.78x
EPS
MEDANTA has higher earnings per share
₹5.9 vs ₹1.55
Dividend Yield
GPTHEALTH has a higher dividend yield
1.58% vs 0.03%
Revenue Growth (TTM YoY)
GPTHEALTH has faster revenue growth
24.6% vs 24.5%
EPS Growth (TTM YoY)
MEDANTA has faster EPS growth
42% vs 13.7%
Qtr Sales Growth
MEDANTA has stronger quarterly sales growth
20.89% vs -0.13%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGPTHEALTHMEDANTA
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricGPTHEALTHMEDANTA
Live Price₹159.38₹1,447.2
Day Change-1.18%-0.85%
Volume97,54174,678
52-Week High₹175₹1,544
52-Week Low₹115₹956
Distance from 52W High-8.93%-6.27%

Valuation

MetricGPTHEALTHMEDANTA
Market Cap₹1,298 Cr₹38,774 Cr
P/E Ratio27.9x69.7x
P/B Ratio4.89x9.78x
EPS₹1.55₹5.9
Book Value₹32.84₹148.18
Dividend Yield1.58%0.03%

Growth

MetricGPTHEALTHMEDANTA
Revenue Growth (TTM YoY)24.6%24.5%
EPS Growth (TTM YoY)13.7%42%
Qtr Sales Growth-0.13%20.89%
Qtr Profit Growth-12.6%14.53%

Profitability & Leverage

MetricGPTHEALTHMEDANTA
ROE15.67%12.37%
ROCE17.26%11.4%
Net Margin8.93%12.62%
Operating Margin13.34%18.62%
Debt to Equity0.06x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGPTHEALTHMEDANTA
Promoter Holding65.57%33% 0.01 pp
FII Holding3.03% 0.22 pp9.46% 0.69 pp
DII Holding6.94% 0.11 pp16.89% 2.13 pp
Public Holding24.46% 0.32 pp40.56% 1.44 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GPT HEALTHCARE and GLOBAL HEALTH.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.